Expand PTGX Menu
PTGX MENU

PTGX Latest Press Releases

-- August 28, 2026 --

Protagonist Therapeutics Announces U.S. FDA Approval of Hepcidin Mimetic Peptide MIMRYLO(TM) (rusfertide) for Polycythemia Vera ACCESS Newswire 8:30 PM

-- August 18, 2026 --

Protagonist Therapeutics Reports Granting of Inducement Awards ACCESS Newswire 4:05 PM

-- August 5, 2026 --

Protagonist Reports Second Quarter 2026 Financial Results and Provides Corporate Update ACCESS Newswire 4:05 PM

-- August 4, 2026 --

Protagonist Therapeutics Reports Granting of Inducement Awards ACCESS Newswire 4:05 PM

-- July 16, 2026 --

Protagonist Therapeutics Reports Granting of Inducement Awards ACCESS Newswire 4:05 PM

-- July 1, 2026 --

Protagonist Therapeutics Reports Granting of Inducement Awards ACCESS Newswire 4:05 PM

-- June 16, 2026 --

Protagonist Therapeutics Reports Granting of Inducement Awards ACCESS Newswire 4:00 PM

-- June 1, 2026 --

Protagonist Therapeutics to Present Phase 3 VERIFY and Long-Term Rusfertide Data at the 2026 European Hematology Association Congress ACCESS Newswire 7:05 AM

-- May 28, 2026 --

Protagonist Therapeutics to Participate in Two Investment Bank Conferences in June 2026 ACCESS Newswire 7:05 AM

-- May 5, 2026 --

Protagonist Reports First Quarter 2026 Financial Results and Provides Corporate Update ACCESS Newswire 4:05 PM

-- April 28, 2026 --

Protagonist Exercises Rusfertide U.S. Opt-Out Right Under Takeda Collaboration ACCESS Newswire 9:05 AM

-- April 16, 2026 --

Protagonist Therapeutics Reports Granting of Inducement Awards ACCESS Newswire 4:05 PM
Market Data Delayed 15 Minutes